The authors describe the qualification of an assay with applications for investigating functional comparability of an originator and biosimilar drug.
Fiona Greer BP
Advertisement
Articles by Fiona Greer BP
Does global development have to entail multiple comparability studies?
Advertisement
Latest Updated Articles
Biosimilar Developers Face a Reference-Product DilemmaPublished: March 1st 2012 | Updated:
Seeking Accelerated Biosimilar CharacterizationPublished: October 15th 2016 | Updated:
Advertisement
Advertisement
